MedPath

Treatment of mature B-cell lymphoma/leukaemia

Not Applicable
Completed
Conditions
eukaemia (acute), lymphoma (non-Hodgkin's)
Cancer
Leukaemia
Registration Number
ISRCTN25173819
Lead Sponsor
Cancer Research UK (CRUK) (UK)
Brief Summary

1. 2007 results in https://www.ncbi.nlm.nih.gov/pubmed/17132719 (added 25/01/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
0
Inclusion Criteria

1. B-large cell, small non-cleaved non-Hodgkin's disease or B-cell leukaemia
2. Stages I-IV
3. Aged over 6 months and under 18 years
4. No previous chemotherapy. Emergency radiotherapy or immunotherapy is permitted
5. No congenital immunodeficiency
6. No prior organ transplantation
7. No previous malignancy of any type
8. No medical contraindications to protocol treatments
9. Patients available for a minimal follow-up of 36 months

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ot provided at time of registration
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath